Acrux heads to the Finnish
Thursday, 14 August, 2008
Acrux [ASX: ACR] has entered into a manufacturing alliance with the Finnish Orion Corporation.
Under the agreement, Orion will become the exclusive manufacturer for Acrux's Testosterone MD-Lotion, as well as a range of transdermal spray products under development.
Acrux retains the rights to supply the products to licensees in all territories.
Both parties will invest in additional equipment at Orion's manufacturing facility as part of the alliance.
Overuse of inhalers can increase heart attack risk
Overuse of reliever inhalers is associated with higher risks of developing and dying from...
Unhealthy Western diet could accelerate cognitive decline
An unhealthy Western-style diet is associated with a faster cognitive decline in people with a...
Cancer drug enters clinical trials based on a false mechanism
A cancer drug currently being tested in patients appears to have entered clinical trials based on...
